Abstract:Background: Several broad lines of evidence support the involvement of epigenetic processes in neurodevelopment and psychiatric disorders. Epigenetic disruption also provides a potential mechanism to account for the numerous gene-environment interactions that have been reported in association with neuropsychiatric phenotypes. Methods: A review of the literature was performed with keywords 'depression', 'depressive disorder' or 'antidepressants' and 'DNA methylation', or 'epigenetics' in humans. Citations were limited to those written in English and published prior to July 2014. Results: We present a summary of results to date. Most studies have focused on DNA methylation in various CNS or peripheral tissue, with almost universally small sample sizes. Although seven epigenome-wide association studies have now been reported, the majority of studies have used a candidate-gene approach. Three genes (SLC6A4, BDNF, NR3C1) have been investigated in more than one study, but replication of findings is generally lacking. Conclusions: Recent evidence provides insights to epigenetic processes in psychiatric disorders; however, replication is lacking and care must be taken in the interpretation of current findings. This applies to epigenetic epidemiology generally, which is subject to various limitations that no single approach can address in isolation. Due to limited focus of most depression studies to date, placing the findings within the broader context of mood disorder pathophysiology may prove challenging. However, identifying peripheral biomarkers for depressive disorder remains a tantalising possibility, especially given the potential for carefully-designed longitudinal studies with multiple biospecimens and ongoing advances in epigenetic technologies.

The Role of Epigenetic Regulation in Etiology of Major Depressive Disorder

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential

DNA Methylation in Schizophrenia: Progress and Challenges

Epigenetics and depressive disorders: a review of current progress and future directions

Epigenetic Modulation: Research Progress on Histone Acetylation Levels in Major Depressive Disorders

Epigenetic Mechanisms in Depression: Implications for Pathogenesis and Treatment.

Epigenetic alterations in depression and antidepressant treatment

Epigenetic Regulation in Schizophrenia: Focus on Methylation and Histone Modifications in Human Studies

The Relevance of Epigenetics to Major Psychosis

A review of DNA methylation in depression

Epigenetics and Depression: An Update

Molecular studies of major depressive disorder: the epigenetic perspective

Investigating the Epigenetic Landscape of Major Depressive Disorder: A Genome-Wide Meta-Analysis of DNA Methylation Data, Including New Insights into Stochastic Epigenetic Mutations and Epivariations

A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder

Epigenetic Aging in Major Depressive Disorder: Clocks, Mechanisms and Therapeutic Perspectives

Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression

The Link Between Long Noncoding RNAs and Depression.

Epigenetic Signaling in Psychiatric Disorders

Epigenetic Mechanisms in the Neurodevelopmental Theory of Depression

Research progress on age-specific epigenetic mechanisms of major depressive disorder